Rahul Bhambri

510 total citations
22 papers, 344 citations indexed

About

Rahul Bhambri is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Rheumatology. According to data from OpenAlex, Rahul Bhambri has authored 22 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Rheumatology. Recurrent topics in Rahul Bhambri's work include Amyloidosis: Diagnosis, Treatment, Outcomes (11 papers), Eosinophilic Disorders and Syndromes (6 papers) and Parathyroid Disorders and Treatments (5 papers). Rahul Bhambri is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (11 papers), Eosinophilic Disorders and Syndromes (6 papers) and Parathyroid Disorders and Treatments (5 papers). Rahul Bhambri collaborates with scholars based in United States, United Kingdom and Australia. Rahul Bhambri's co-authors include Élodie Ramos, Eric Druyts, Kristian Thorlund, Mark H. Rozenbaum, Ahmad Masri, Michelle Stewart, José Nativi-Nicolau, Jeffery Robbins, Noel R. Dasgupta and Michel Lantéri‐Minet and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and Headache The Journal of Head and Face Pain.

In The Last Decade

Rahul Bhambri

22 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rahul Bhambri United States 9 132 132 86 75 51 22 344
Yifan Liang China 12 37 0.3× 68 0.5× 11 0.1× 67 0.9× 30 0.6× 18 339
Shaloo Pandhi Switzerland 8 69 0.5× 39 0.3× 54 0.6× 72 1.0× 8 0.2× 11 282
Takenori Sakai Japan 12 66 0.5× 47 0.4× 11 0.1× 89 1.2× 30 0.6× 41 453
Hikaru Aoki Japan 10 124 0.9× 76 0.6× 16 0.2× 24 0.3× 17 0.3× 47 435
Radmila Obrenović Serbia 12 13 0.1× 49 0.4× 39 0.5× 65 0.9× 58 1.1× 39 336
Yu‐Chiao Chi Taiwan 10 34 0.3× 109 0.8× 24 0.3× 178 2.4× 11 0.2× 15 408
Antonio Polini Italy 12 44 0.3× 76 0.6× 43 0.5× 43 0.6× 3 0.1× 19 532
Hirokuni Hatanaka Japan 10 78 0.6× 55 0.4× 16 0.2× 135 1.8× 9 0.2× 19 380
Sandra Rutz Germany 9 118 0.9× 73 0.6× 9 0.1× 153 2.0× 70 1.4× 14 324

Countries citing papers authored by Rahul Bhambri

Since Specialization
Citations

This map shows the geographic impact of Rahul Bhambri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rahul Bhambri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rahul Bhambri more than expected).

Fields of papers citing papers by Rahul Bhambri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rahul Bhambri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rahul Bhambri. The network helps show where Rahul Bhambri may publish in the future.

Co-authorship network of co-authors of Rahul Bhambri

This figure shows the co-authorship network connecting the top 25 collaborators of Rahul Bhambri. A scholar is included among the top collaborators of Rahul Bhambri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rahul Bhambri. Rahul Bhambri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masri, Ahmad, Yong Chen, Aaron Crowley, et al.. (2025). Coexisting Calcific Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Real‐World Evaluation of Clinical Characteristics and Outcomes. Journal of the American Heart Association. 14(2). e033251–e033251. 2 indexed citations
2.
Bhambri, Rahul, et al.. (2023). Artificial intelligence–enabled tools in cardiovascular medicine: A survey of current use, perceptions, and challenges. PubMed. 4(3). 101–110. 20 indexed citations
3.
Bhambri, Rahul, Marianna Bruno, Yong Chen, et al.. (2023). Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United States. American Journal of Cardiovascular Drugs. 23(2). 197–206. 5 indexed citations
4.
Bourque, Jamieson M., Rahul Bhambri, Adam Castaño, et al.. (2022). Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population. The American Journal of Cardiology. 167. 98–103. 7 indexed citations
5.
Roy, Anuja, Andrew M. Peterson, José Alvir, et al.. (2022). Baseline Characteristics and Secondary Medication Adherence Patterns Among Patients Receiving Tafamidis Prescriptions: A Retrospective Analysis Using a National Specialty Pharmacy Dispensing Database. Patient Preference and Adherence. Volume 16. 1115–1129. 4 indexed citations
6.
Rozenbaum, Mark H., et al.. (2022). Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy. American Journal of Cardiovascular Drugs. 22(4). 445–450. 8 indexed citations
7.
8.
9.
Rozenbaum, Mark H., Rahul Bhambri, Michelle Stewart, et al.. (2021). Impact of Delayed Diagnosis and Misdiagnosis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Targeted Literature Review. Cardiology and Therapy. 10(1). 141–159. 67 indexed citations
10.
Bourque, Jamieson M., Rahul Bhambri, Adam Castaño, et al.. (2021). TEMPORAL TRENDS IN DIAGNOSTIC TESTING PATTERNS FOR WILD-TYPE TRANSTHYRETIN AMYLOID CARDIOMYOPATHY IN THE MEDICARE FEE-FOR-SERVICE POPULATION. Journal of the American College of Cardiology. 77(18). 528–528. 1 indexed citations
11.
Rozenbaum, Mark H., Rahul Bhambri, Michelle Stewart, et al.. (2021). Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy. Journal of Comparative Effectiveness Research. 10(11). 927–938. 13 indexed citations
12.
Thorlund, Kristian, Ping Wu, Eric Druyts, et al.. (2016). Comparative tolerability of treatments for acute migraine: A network meta-analysis. Cephalalgia. 37(10). 965–978. 47 indexed citations
13.
Bhambri, Rahul, et al.. (2016). FDA’s Expedited Programs and Their Impact on the Availability of New Therapies. Therapeutic Innovation & Regulatory Science. 51(1). 24–28. 7 indexed citations
14.
Thorlund, Kristian, Christina Sun‐Edelstein, Eric Druyts, et al.. (2016). Risk of medication overuse headache across classes of treatments for acute migraine. The Journal of Headache and Pain. 17(1). 107–107. 79 indexed citations
15.
Jeffers, Barrett W., Jeffery Robbins, Rahul Bhambri, & Dalia Wajsbrot. (2015). A Systematic Review on the Efficacy of Amlodipine in the Treatment of Patients With Hypertension With Concomitant Diabetes Mellitus and/or Renal Dysfunction, When Compared With Other Classes of Antihypertensive Medication. American Journal of Therapeutics. 22(5). 322–341. 17 indexed citations
16.
Bhambri, Rahul, Jack Mardekian, Larry Liu, Edward E. Schweizer, & Élodie Ramos. (2015). A review of the pharmacoeconomics of eletriptan for the acute treatment of migraine. International Journal of General Medicine. 8. 27–27. 5 indexed citations
17.
18.
Jeffers, Barrett W., Rahul Bhambri, & Jeffery Robbins. (2014). Incremental Blood Pressure–Lowering Effect of Titrating Amlodipine for the Treatment of Hypertension in Patients Including Those Aged ≥55 Years. American Journal of Therapeutics. 22(4). 278–287. 2 indexed citations
19.
Jeffers, Barrett, Rahul Bhambri, & Jeffery Robbins. (2014). Uptitrating amlodipine significantly reduces blood pressure in diabetic patients with hypertension: a retrospective, pooled analysis. Vascular Health and Risk Management. 10. 651–651. 4 indexed citations
20.
Abdulsattar, Younos, et al.. (2009). Rivaroxaban (xarelto) for the prevention of thromboembolic disease: an inside look at the oral direct factor xa inhibitor.. PubMed Central. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yifan Liang Breakdown of academic impact, for papers by Shaloo Pandhi Breakdown of academic impact, for papers by Takenori Sakai Breakdown of academic impact, for papers by Hikaru Aoki Breakdown of academic impact, for papers by Radmila Obrenović Breakdown of academic impact, for papers by Yu‐Chiao Chi Breakdown of academic impact, for papers by Antonio Polini Breakdown of academic impact, for papers by Hirokuni Hatanaka Breakdown of academic impact, for papers by Sandra Rutz
Rankless by CCL
2026